Humoral Response Against Myelin Antigens in Two Strains of Rats with Different Susceptibility to Experimental Allergic Encephalomyelitis (EAE)

References

• Maggio B., Cumar F. A., Roth G. A., Monferrán C. G., Fidelio G. D. Neurochemical and model membrane studies in demyelinating diseases. Acta Neuropathol. (Berlin) 1983; 9(Suppl)71–85
   Google Scholar
• Raine C. S. Experimental allergic encephalomyelitis and experimental allergic neuritis. Handb. Clin. Neurol. 1985; 47: 429–466
   Google Scholar
• Tabira T. Autoimmune demyelination in the central nervous system. Ann. NY Acad. Sci. 1988; 540: 187–201
   PubMedGoogle Scholar
• Hughes R. A.C., Stedronska J. The susceptibility of rat strains to experimental allergic encephalomyelitis. Immunology 1973; 24: 879–884
   PubMed Web of Science ®Google Scholar
• Roth G. A., Obata K. Experimental allergic encephalomyelitis: Dissociation of immunochemical and clinicopathological responses in two strains of rats. Neurochem. Int. 1991; 19: 213–220
   Web of Science ®Google Scholar
• Encinas J. A., Weiner H. L., Kuchroo V. K. Inheritance of susceptibility to experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1996; 45: 655–669
   PubMed Web of Science ®Google Scholar
• de Brito F. B., Hanahoe T. H.P. Susceptibility of two colonies of Wistar rats to inflammation, with particular reference to delayed hypersensitivity. Int. Archs. Allergy Appl. Immun. 1983; 72: 164–169
   PubMedGoogle Scholar
• Tabira T., Kira J.-I. Strain and species differences of encephalitogenic determinants of myelin basic protein and proteolipid apoprotein. Myelin: Biology and Chemistry, R. E. Martenson. CRC Press, Boca Raton, FL 1992; 783–800
   Google Scholar
• Happ M. P., Wettstein P., Dietzschold B., Heber-Katz E. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. J. Immunol. 1988; 141: 1489–1494
   PubMed Web of Science ®Google Scholar
• Fugger L., Liang J., Gautam A., Rothbard J. B., Mcdevitt H. O. Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-A (U), which confers susceptibility to experimental allergic encephalomyelitis. Mol. Med. 1996; 2: 181–188
   PubMed Web of Science ®Google Scholar
• Sternberg E. M., Hill J. M., Chrousos G. P., Kamilaris T., Listwak S. J., Gold P. W., Wilder R. L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. USA 1989; 86: 2374–2378
   PubMed Web of Science ®Google Scholar
• Hashim G. A., Day E. D. Role of antibodies in T cell-mediated experimental allergic encephalomyelitis. J. Neurosci. Res. 1988; 21: 1–5
   PubMed Web of Science ®Google Scholar
• Karpus W. J., Swanborg R. H. Protection against experimental allergic encephalomyelitis requires both CD4+ T-suppressor cells and myelin basic-primed B cells. J. Neuroimmunol. 1991; 33: 173–177
   PubMed Web of Science ®Google Scholar
• Willenborg D. O., Sjollema P., Danta G. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis. J. Neuroimmunol. 1986; 11: 93–103
   PubMed Web of Science ®Google Scholar
• Myers K. J., Sprent J., Dougherty J. P., Ron Y. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1992; 41: 1–8
   PubMed Web of Science ®Google Scholar
• Wolf S. D., Dittle B. N., Hardardottir F., Janeway C. A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996; 184: 2271–2278
   PubMed Web of Science ®Google Scholar
• McFarlin D. E., Hsu S. C., Slemenda S. B., Chou F. C., Kibler R. F. The immune response against myelin basic protein in two strains of rat with different genetic capacity to develop experimental allergic encephalomyelitis. J. Exp. Med. 1975; 141: 72–81
   PubMed Web of Science ®Google Scholar
• Roth G. A., Yu R. K., Bornstein M. B. Chemical analysis of organotypic cultures of mouse spinal cord in normal, demyelinative, and nondemyelinative conditions. J. Neurochem. 1983; 41: 1710–1717
   PubMed Web of Science ®Google Scholar
• Nishizawa M., Tanaka M., Inizuka T., Tanaka K., Baba H., Miyatami N., Sato S., Miyatake T. Production and characterization of monoclonal antibodies against myelin-associated glycoprotein. J. Neurochem. 1986; 47: 1893–1900
   PubMed Web of Science ®Google Scholar
• Rivero V. E., Maccioni M., Bucher A. E., Roth G. A., Riera C. M. Suppression of experimental autoimmune encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats. J. Neuroimmunol. 1997; 72: 3–10
   PubMed Web of Science ®Google Scholar
• Lando Z., Teitelbaum D., Arnon R. Induction of EAE in genetically resistant strains of mice. Nature 1980; 287: 551–552
   PubMed Web of Science ®Google Scholar
• Beraud E., Reshef T., Vandenbark A. A., Offner H., Friz R., Chou C.-H. J., Bernard D., Cohen I. R. Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immuno dominant epitope of basic protein. J. Immunol. 1986; 136: 511–515
   PubMed Web of Science ®Google Scholar
• Trotter J., Zamvill A. A., Steinman L. Comparison of antigen specificity, class II major histocompatibility complex restriction and in vivo behavior of myelin basic protein-specific T cell lines and clones derived from (BALE/c × SJL/J) mice. J. Immunol. 1987; 139: 1834–1839
   PubMed Web of Science ®Google Scholar
• Abromson-Leeman S., Hayashi M., Martin C., Sobel R., Al-Sabbagh A., Weiner H., Dorf M. E. T cell response to myelin basic protein in experimental autoimmune encephalomyelitis-resistant BALB/c mice. J. Neuroimmunol. 1993; 45: 89–96
   PubMed Web of Science ®Google Scholar
• Mustafa M., Vingsbo C., Olsson T., Issazadeh S., Ljungdahl A., Holmdahl R. Protective influences on experimental autoimmuneencephalomyelitis by MHCclass I and Class II allcles. J. Immunol. 1994; 153: 3337–3344
   PubMed Web of Science ®Google Scholar
• Issazadeh S., Kjellen P., Olsson T., Mustafa M., Holmdahl R. Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific. Eur. J. Immunol. 1997; 27: 1584–1587
   PubMed Web of Science ®Google Scholar
• Mostarica-Stojkovic M., Petrovic M., Lukic M. L. Resistance to the induction of EAE in AO rats: its prevention by the pre-treatment with cyclophosphamide or low dose of irradiation. Clin. Exp. Immunol. 1982; 50: 311–317
   PubMed Web of Science ®Google Scholar
• Abromson-Leeman S., Alexander J., Bronson R., Carroll J., Southwood S., Dorf M. E. Experimental allergic encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II. J. Immunol. 1995; 154: 388–398
   PubMed Web of Science ®Google Scholar
• Shaw M. K., Kim C., Ho K. H., Lisak R. P., Tse H. Y. A combination of adoptive transfer and antigenic challenge induces consistent murine autoimmune encephalomyelitis in C57BL/6 mice and other reputed resistant strains. J. Neuroimmunol. 1992; 39: 139–150
   PubMed Web of Science ®Google Scholar
• Levine S., Sowinski R. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. J. Immunol. 1975; 114: 597–601
   PubMed Web of Science ®Google Scholar
• Saudi A., Kuhn J., Huygen K., De Kozak Y., Velu T., Goldman M., Druet P., Bellon B. Th2 activated cells prevent experimental autoimmune uveoretinitis, a Th1-dependant autoimmune disease. Eur. J. Immunol. 1993; 23: 3096–3103
   PubMed Web of Science ®Google Scholar
• Der Balian G. P., Slack J., Clevinger B. L., Bazin H., Davie J. M. Subclass restriction of murine antibodies. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats. J. Exp. Med. 1980; 152: 209–218
   PubMed Web of Science ®Google Scholar
• Sayavey M. H., Akalin E., Hancok W. W., Russel M. E., Carpenter C. B., Linsley P. S., Turka L. A. CD 28-B7 blockade after allogenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 1995; 181: 1869–1874
   PubMed Web of Science ®Google Scholar
• Smith L. A., Rumanjanek V. M. Transfer of protection against allergic encephalomyelitis from mother to offspring. Immunology 1984; 51: 201–204
   PubMed Web of Science ®Google Scholar
• MacPhee I. A., Day M. J., Mason D. W. The role of serum factors in the suppression of EAE evidence for immunoregulation by antibody to encephalitogenic peptide. Immunology 1990; 70: 527–534
   PubMed Web of Science ®Google Scholar
• Rott O., Bernard F., Cash E. Interleukin-10 prevents experimental allergic encephalornyelitis in rats. Eur. J. Immunol. 1994; 24: 1434–1440
   PubMed Web of Science ®Google Scholar
• Bach J.-F. Organ-specific autoimmunity. Immunol. Today 1995; 16: 353–355
   PubMedGoogle Scholar
• Kumar V., Sercarz E. Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity. J. Neurosci. Res. 1996; 45: 334–339
   PubMed Web of Science ®Google Scholar
• Slattery R. M., Miller J. F.A.P., Heath W. R., Charlton B. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1993; 90: 10808–10810
   PubMed Web of Science ®Google Scholar
• Wen L., Roberts S. J., Viney J. L., Wong F. S., Mallick C., Findly R. C., Peng Q., Craft J. E., Owen M J., Hayday A. C. Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ(+) T cells. Nature 1994; 369: 654–658
   PubMed Web of Science ®Google Scholar
• Ando D. G., Clayton J., Kono D., Urban J. L., Sercarz E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalornyelitis (EAE) are of Th1 lymphokine subtype. Cell Immunol. 1989; 124: 132–143
   PubMed Web of Science ®Google Scholar
• Racke M. K., Bonomo A., Scott D. E., Cannella B., Levine A., Raine C. S., Shevach E. M., Röcken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994; 180: 1961–1966
   PubMed Web of Science ®Google Scholar
• Karpus W. J., Gould K. E., Swanborg R. H. CD4+ suppressor cells of autoimmune encephalornyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Neurosci. 1992; 22: 1757–1763
   Google Scholar
• Khoury S. J., Hancock W. W., Weiner H. L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalornyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin-4 and prostaglandin E in the brain. J. Exp. Med. 1992; 176: 1355–1364
   PubMed Web of Science ®Google Scholar
• Leonard J. P., Waldburger K. E., Goldman S. J. Prevention of experimental autoimmune encephalornyelitis by antibodies against Interleukin 12. J. Exp. Med. 1995; 181: 381–386
   PubMed Web of Science ®Google Scholar
• Kelso A. Th1 and Th2 subsets: paradigms lost?. Immunol. Today 1995; 16: 374–379
   PubMedGoogle Scholar